TABLE 3.
Arterial plasma C-peptide, glucagon, and cortisol levels before treatment (0 min) and during the experimental period (65–485 min)
Mean ± S.E.M.; n = 9 per group.
0 | 65 | 125 | 185 | 245 | 305 | 365 | 425 | 485 | |
---|---|---|---|---|---|---|---|---|---|
Arterial plasma C-peptide (ng/ml) | |||||||||
Inhalation | 0.21 ± 0.03 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.03 ± 0.01 | 0.03 ± 0.01 | 0.02 ± 0.01 | 0.03 ± 0.01 | 0.06 ± 0.03 | 0.06 ± 0.04 |
Intravenous infusion | 0.26 ± 0.07 | 0.04 ± 0.02 | 0.04 ± 0.01 | 0.05 ± 0.02 | 0.05 ± 0.02 | 0.04 ± 0.01 | 0.04 ± 0.02 | 0.05 ± 0.02 | 0.08 ± 0.04 |
Arterial plasma glucagon (pg/ml) | |||||||||
Inhalation | 39 ± 4 | 37 ± 3 | 35 ± 2 | 35 ± 1 | 37 ± 2 | 36 ± 2 | 33 ± 2 | 33 ± 2 | 29 ± 2 |
Intravenous infusion | 42 ± 3 | 51 ± 2 | 41 ± 3 | 37 ± 5 | 41 ± 3 | 38 ± 2 | 38 ± 3 | 33 ± 3 | 37 ± 3 |
Arterial plasma cortisol (μg/ml) | |||||||||
Inhalation | 5.5 ± 0.9 | 6.7 ± 1.7 | 5.1 ± 1.4 | 3.4 ± 0.4 | 2.4 ± 0.2 | 2.5 ± 0.5 | 3.5 ± 0.5 | 3.9 ± 1.0 | 3.6 ± 0.4 |
Intravenous infusion | 10.7 ± 1.9 | 7.8 ± 1.1 | 4.0 ± 0.6 | 3.9 ± 0.6 | 3.1 ± 0.5 | 3.3 ± 0.5 | 4.0 ± 0.9 | 3.5 ± 0.6 | 5.4 ± 1.1 |